Mackenzie Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.34M Sell
21,292
-80,619
-79% -$20.1M 0.01% 651
2025
Q4
$28.2M Buy
101,911
+9,241
+10% +$2.53M 0.03% 340
2025
Q3
$24.3M Buy
92,670
+84,260
+1,002% +$20.5M 0.03% 350
2025
Q2
$1.84M Sell
8,410
-83
-1% -$17.7K ﹤0.01% 826
2025
Q1
$1.9M Buy
8,493
+929
+12% +$256K ﹤0.01% 802
2024
Q4
$2.48M Buy
7,564
+634
+9% +$200K ﹤0.01% 718
2024
Q3
$2.08M Sell
6,930
-399
-5% -$122K ﹤0.01% 716
2024
Q2
$2.41M Sell
7,329
-318
-4% -$112K ﹤0.01% 690
2024
Q1
$3.03M Buy
7,647
+270
+4% +$99.9K ﹤0.01% 651
2023
Q4
$2.6M Sell
7,377
-7,932
-52% -$2.81M ﹤0.01% 678
2023
Q3
$5.65M Buy
15,309
+8,043
+111% +$3.11M 0.01% 524
2023
Q2
$2.75M Sell
7,266
-2,619
-26% -$936K ﹤0.01% 671
2023
Q1
$3.42M Buy
9,885
+83
+0.8% +$24.3K 0.01% 625
2022
Q4
$2.31M Sell
9,802
-890
-8% -$211K ﹤0.01% 650
2022
Q3
$2.63M Buy
10,692
+464
+5% +$141K ﹤0.01% 637
2022
Q2
$3.09M Buy
10,228
+265
+3% +$86.2K 0.01% 623
2022
Q1
$4.09M Buy
9,963
+89
+0.9% +$34.8K 0.01% 616
2021
Q4
$4.63M Sell
9,874
-5,838
-37% -$2.51M 0.01% 592
2021
Q3
$6.67M Buy
15,712
+6,370
+68% +$2.69M 0.01% 521
2021
Q2
$3.35M Buy
9,342
+1,260
+16% +$416K ﹤0.01% 633
2021
Q1
$2.28M Buy
8,082
+1,128
+16% +$323K ﹤0.01% 667
2020
Q4
$1.97M Sell
6,954
-4,170
-37% -$1.17M ﹤0.01% 610
2020
Q3
$3.06M Buy
11,124
+1,638
+17% +$433K 0.01% 482
2020
Q2
$2.15M Buy
9,486
+2,486
+36% +$488K 0.01% 546
2020
Q1
$1.07M Buy
7,000
+5,594
+398% +$861K ﹤0.01% 627
2019
Q4
$211K Buy
+1,406
New +$205K ﹤0.01% 1032
2019
Q1
Sell
-2,455
Closed -$241K 1331
2018
Q4
$241K Buy
2,455
+228
+10% +$24.7K ﹤0.01% 1070
2018
Q3
$275K Buy
+2,227
New +$250K ﹤0.01% 1012

Other funds holding WST